Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 26, 2023 08:00 ET | Source: Purdue Research Foundation

Purdue Research Foundation monetizes Pluvicto royalty interests to fund further research at Purdue University

WEST LAFAYETTE, Ind. and NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Purdue Research Foundation, a private not-for-profit institute to advance the research of Purdue University, has received more...
April 14, 2023 20:19 ET | Source: NKGen Biotech

NKGen Biotech, Inc. to Become Publicly Traded Company via Business Combination with Graf Acquisition Corp. IV

NKGen Biotech, Inc. (“NKGen”), a clinical stage Natural Killer (NK) cell therapy company, has entered into a merger agreement with Graf Acquisition Corp. IV NKGen Biotech, Inc.’s non-genetically...
April 13, 2023 16:30 ET | Source: Bitdeer Technologies Group

Bitdeer and Blue Safari Complete Business Combination

- Bitdeer to Debut on Nasdaq on April 14, 2023 - Bitdeer Shares to Trade Under Ticker “BTDR” SINGAPORE, April 14, 2023 (GLOBE NEWSWIRE) -- Bitdeer Technologies Group (“Bitdeer”), a world-leading...
April 04, 2023 02:32 ET | Source: Zealand Pharma

Zealand Pharma completes registration of capital increase

Company announcement – No. 14 / 2023 Zealand Pharma completes registration of capital increase NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES,...
March 30, 2023 16:45 ET | Source: Zealand Pharma

Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion

Company announcement – No. 11 / 2023 Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5...
March 30, 2023 11:01 ET | Source: Zealand Pharma

Zealand Pharma announces directed issue and private placement of approximately 6.5 million new shares

Company announcement – No. 10 / 2023 Zealand Pharma announces directed issue and private placement of approximately 6.5 million new shares NOT FOR RELEASE, PUBLICATION OR...
March 30, 2023 07:05 ET | Source: Scynexis

GSK and SCYNEXIS Announce an Exclusive Agreement to Commercialise and Further Develop Brexafemme (ibrexafungerp), a Novel, First-in-Class Medicine to Treat Fungal Infection

Brexafemme complements GSK’s industry-leading infectious disease portfolio with an FDA approved treatment for vulvovaginal candidiasisSCYNEXIS will receive an upfront payment of $90 million with...
March 20, 2023 16:25 ET | Source: CalciMedica

CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement

- CalciMedica common stock to commence trading on Nasdaq Global Market on March 21, 2023 under ticker symbol “CALC”- Cash and cash equivalents of approximately $34 million as of merger close expected...
February 22, 2023 17:15 ET | Source: Lucira Health Inc.

Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process

EMERYVILLE, Calif., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) (“Lucira Health,” “Lucira” or the “Company”), a medical technology company, announced today that it has filed...
January 17, 2023 05:00 ET | Source: Angion Biomedica Corp.

Elicio Therapeutics and Angion Enter into Definitive Merger Agreement

Merger to result in Nasdaq-listed company focused on developing immunotherapies based on Elicio’s proprietary lymph node-targeting Amphiphile (AMP) technologyLead program of the combined company will...